However, it should be noted that off-target tumours occurred in a sizeable proportion of BPRN mice and included lymphoma, thyroid, lung, skin, and breast malignancies; this is not surprising given that some mice contained germline alterations in Brca1 and Trp53 and the long latency to tumour development. This evidence concerns the gene BRCA1 and lymphoma.